Are Early Relapses in Advanced-Stage Ovarian Cancer Doomed to a Poor Prognosis? - Wikidata - wikimedia - TriplyDB

Are Early Relapses in Advanced-Stage Ovarian Cancer Doomed to a Poor Prognosis?

Are Early Relapses in Advanced-Stage Ovarian Cancer Doomed to a Poor Prognosis?

http://www.wikidata.org/entity/Q35907074

about

Factors favouring long-term survival following recurrence in ovarian cancer.

P2860

Q33857691-EDDDB202-00F4-4983-9965-4EF839FE0663

P2860

Are Early Relapses in Advanced-Stage Ovarian Cancer Doomed to a Poor Prognosis?

http://www.wikidata.org/entity/Q35907074

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Are Early Relapses in Advanced-Stage Ovarian Cancer Doomed to a Poor Prognosis?

@ast

Are Early Relapses in Advanced-Stage Ovarian Cancer Doomed to a Poor Prognosis?

@en

type

label

Are Early Relapses in Advanced-Stage Ovarian Cancer Doomed to a Poor Prognosis?

@ast

Are Early Relapses in Advanced-Stage Ovarian Cancer Doomed to a Poor Prognosis?

@en

prefLabel

Are Early Relapses in Advanced-Stage Ovarian Cancer Doomed to a Poor Prognosis?

@ast

Are Early Relapses in Advanced-Stage Ovarian Cancer Doomed to a Poor Prognosis?

@en

P1433

Q35907074-5EB9651B-765A-43E1-8CC5-F344AC64F589

P1476

Q35907074-AF2C9789-7800-4D9E-98F4-073314C11928

P2093

Q35907074-035C655C-AF0E-4DF5-A35F-677FACB469A3

Q35907074-48E97CD9-4F91-4E18-928F-063601B5E276

Q35907074-4FB27820-B56E-42E4-A0E5-C0FC256B8A56

Q35907074-7272FFED-C427-4505-9B68-841F7755190C

Q35907074-9052D811-7742-4872-B07D-6D5C3CC4E6E0

Q35907074-9D5CC833-3D8C-48A0-B333-B383D11F7AE2

Q35907074-AC6078ED-5EFB-4804-A022-0F4CD6827D7B

Q35907074-B2BFFD3C-530D-4D06-A9CA-4C9D2794B3A1

Q35907074-CF54D346-B69C-424E-A40A-F1913FCA4614

Q35907074-E6268F8A-CEB9-44CE-9FE8-8A9CEF5D2782

P2860

Q35907074-038F909B-B97F-4408-94F6-C89CA63647C3

Q35907074-04C4DD2A-16AC-496E-BBBC-D413E1309E4F

Q35907074-1F7ACFEF-6B88-43E5-BB74-0D5C834F543E

Q35907074-3245A247-AE3E-4FC0-8B9F-25F2FAE591DC

Q35907074-338EE0F0-97BE-4D82-9628-FADA6C57AD7E

Q35907074-3BA4F875-AF35-495A-BC1E-AA1696D32B74

Q35907074-55758017-2AC3-4A72-BB8A-AC5948963BE5

Q35907074-6D456A09-90AF-4A65-A609-62BB20334F6D

Q35907074-9201D2EB-366D-49B2-B22A-3F8CC7EB8BDF

Q35907074-952748C9-AF5D-4085-A853-92BCBB75953A

P304

Q35907074-00E6A360-4C83-4E4D-8D4E-93428EF31C44

P31

Q35907074-8191E4DD-6954-4044-8C72-60A1DB85F4E9

P356

Q35907074-60298C0F-C8E7-45FF-801F-05D96FF714EA

P407

Q35907074-A5AF8BF1-3972-4141-8A19-B1BCB3F9E1DF

P433

Q35907074-825DB43B-3D36-41AF-9B64-E00D77F5906E

P478

Q35907074-099437F6-8723-4F54-AC3D-B66906C3DF98

P50

Q35907074-0A1000DB-3897-4039-B037-54CA03A99341

Q35907074-349E05CC-AB76-4B9E-921C-9D7DAA2535AC

Q35907074-C325E5D9-5666-427A-BA22-0B63D8D09816

Q35907074-EE4984A6-5F02-49F0-8A95-4AB003E2251C

Q35907074-FBF39156-B97D-4DD8-BB71-FC30BCC1973F

P577

Q35907074-75560850-81F9-4D9C-BB11-F4A9013DA1ED

P5875

Q35907074-86B1ECA7-6ED7-49C3-8693-6E5FDA763743

P698

Q35907074-FD2A3CEA-3797-4B25-886D-7F9E39FB7FAB

P932

Q35907074-08AFBE02-8B43-41B4-9015-B2ABA11FC9E4

P356

JOURNAL.PONE.0147787

P1433

P1476

Are Early Relapses in Advanced-Stage Ovarian Cancer Doomed to a Poor Prognosis?

@en

P2093

Arash Rafii

http://www.w3.org/2001/XMLSchema#string

Christophe Pomel

http://www.w3.org/2001/XMLSchema#string

Denis Querleu

http://www.w3.org/2001/XMLSchema#string

Eberhard Stoeckle

http://www.w3.org/2001/XMLSchema#string

Fabien Vidal

http://www.w3.org/2001/XMLSchema#string

Fabrice Lecuru

http://www.w3.org/2001/XMLSchema#string

Gwenael Ferron

http://www.w3.org/2001/XMLSchema#string

Jean Marc Classe

http://www.w3.org/2001/XMLSchema#string

Pascale Haddad

http://www.w3.org/2001/XMLSchema#string

Paul Guerby

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2012

Cancer statistics, 2008

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis.

Mesenchymal cell interaction with ovarian cancer cells triggers pro-metastatic properties

Randomized trial of pegylated liposomal doxorubicin (PLD) plus carboplatin versus carboplatin in platinum-sensitive (PS) patients with recurrent epithelial ovarian or peritoneal carcinoma after failure of initial platinum-based chemotherapy (Southwe

Mesenchymal stem cells enhance ovarian cancer cell infiltration through IL6 secretion in an amniochorionic membrane based 3D model.

Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.

Management strategies for recurrent platinum-resistant ovarian cancer.

Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells.

Secondary cytoreductive surgery for ovarian cancer.

P304

e0147787

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0147787

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Thomas Filleron

Philippe Morice

P577

2016-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

292153427

http://www.w3.org/2001/XMLSchema#string

P698

26820579

http://www.w3.org/2001/XMLSchema#string

P932

4731146

http://www.w3.org/2001/XMLSchema#string